Benefits of a Molecular-Based Method for the Detection of Clarithromycin-Resistant Helicobacter pylori

참고문헌 (9)

1. Sung H, "Global cancer statistics 2020 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries", CA Cancer J Clin, 71, pp.209~249 (2021)
2. Yoon SB, "Effect of Helicobacter pylori eradication on metachronous gastric cancer after endoscopic resection of gastric tumors : a metaanalysis", Helicobacter, 19, pp.243~248 (2014)
3. Kuo YT, "Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region : a systematic review and meta-analysis", Lancet Gastroenterol Hepatol, 2, pp.707~715 (2017)
4. Kim Sang Yoon, "Types of 23S Ribosomal RNA Point Mutations and Therapeutic Outcomes for Helicobacter pylori", Gut and Liver, 15(4), pp.528~536 (2021), 거트앤리버 소화기연관학회협의회[DOI]
5. Marques AT, "Trends in Helicobacter pylori resistance to clarithromycin : from phenotypic to genomic approaches", Microb Genom, 6, pp.e000344~ (2020)
6. Sakinc T, "Influence of a 23S ribosomal RNA mutation in Helicobacter pylori strains on the in vitro synergistic effect of clarithromycin and amoxicillin", BMC Res Notes, 5, pp.603~ (2012)
7. Evariste Tshibangu-Kabamba, "Helicobacter pylori infection and antibiotic resistance — from biology to clinical implications", Nature Reviews Gastroenterology & Hepatology, 18(9), pp.613~629 (2021), Springer Science and Business Media LLC[DOI]
8. Ong S, "Helicobacter pylori eradication rates with concomitant and tailored therapy based on 23S rRNA point mutation : a multicenter randomized controlled trial", Helicobacter, 24, pp.e12654~ (2019)
9. Binh TT, "Discovery of novel mutations for clarithromycin resistance in Helicobacter pylori by using next-generation sequencing", J Antimicrob Chemother, 69, pp.1796~1803 (2014)